IL10 and neoplasm: This is because tumours release FTH1 to induce an immunosuppressive microenvironment by re-programming dendritic cells so they induce production of the anti-inflammatory cytokine IL-10 from regulatory T cells, hence, allowing the tumour to escape immune surveillance37.